| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,655 |
20,958 |
$936K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
17,699 |
5,791 |
$522K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,406 |
11,055 |
$503K |
| 99233 |
Prolong inpt eval add15 m |
8,256 |
4,042 |
$391K |
| 99223 |
Prolong inpt eval add15 m |
2,430 |
2,171 |
$209K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
9,043 |
2,923 |
$140K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,522 |
1,401 |
$112K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,067 |
1,860 |
$96K |
| 95886 |
|
514 |
475 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,132 |
1,006 |
$24K |
| 99222 |
Initial hospital care, per day, moderate complexity |
470 |
416 |
$22K |
| 95910 |
|
17 |
13 |
$2K |
| 27096 |
|
28 |
24 |
$2K |
| 20610 |
|
63 |
50 |
$1K |
| 64483 |
|
12 |
12 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
84 |
69 |
$707.72 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
4,683 |
4,161 |
$0.00 |
| 1036F |
|
6,212 |
5,466 |
$0.00 |
| G9585 |
Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy |
45 |
43 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,047 |
1,779 |
$0.00 |
| G9579 |
No documentation of signed an opioid treatment agreement at least once during opioid therapy |
428 |
363 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
294 |
252 |
$0.00 |
| G9745 |
Documented reason for not screening or recommending a follow-up for high blood pressure |
236 |
226 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
14 |
13 |
$0.00 |
| 4004F |
|
4,788 |
4,251 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
6,878 |
6,086 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
10,418 |
9,249 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
10,905 |
9,682 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
11,203 |
9,951 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
894 |
807 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
13,090 |
11,489 |
$0.00 |
| 4040F |
|
88 |
84 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,445 |
4,834 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
353 |
323 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
238 |
221 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
25 |
23 |
$0.00 |